A missense variant in the GIPR, E354Qwhereby a glutamine (Q) at amino acid position 354 replaces a glutamic acid (E), identified in a genome-wide association study (GWAS), is linked with increased risk of T2D and higher BMI (Speliotes et al., 2010)
It is really sleek and a nice shade of red
Bring them up with your healthcare provider, especially if you experience: Sustained low mood or loss of interest lasting more than two weeks Increased anxiety or panic episodes that werent present before treatment Unusual irritability or emotional reactivity that interferes with daily life Thoughts of self-harm or suicide (seek immediate help
What This Means for Patients If you are waiting for retatrutide: it will not be available by prescription before the second half of 2027 at the absolute earliest under an optimistic priority-review scenario, and realistically mid-to-late 2028 under standard review
Current investigations focus on peptide-mediated regulation of growth factor expression, hypothalamic-pituitary communication, and anabolic signaling pathways
Giving the wrong starting dose is the most common clinical error with this drug